Clinical Trial Detail

NCT ID NCT03268057
Title VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Vaccinex Inc.
Indications

lung non-small cell carcinoma

Therapies

Avelumab + VX15/2503

Age Groups: senior adult

Additional content available in CKB BOOST